WHO Preferred Product Characteristics for Therapeutic Vaccines to Improve Tuberculosis Treatment Outcomes
Document uniquement disponible en anglais
PDF
We value your privacy
We use cookies on our website to give you the most relevant experience by remembering your preferences
during repeat visits. By clicking “Accept”, you consent to the use of all the cookies.
TB KaSPar
Retour